Extended follow-up after wearable cardioverter-defibrillator period: the PROLONG-II study.
Johanna Mueller-LeisseJohanna BrunnChristos ZormpasStephan HohmannHenrike Aenne Katrin HillmannJörg EiringhausJohann BauersachsChristian VeltmannDavid DunckerPublished in: ESC heart failure (2021)
Patients with WCD shocks showed a favourable survival. Patients without an ICD recommendation after WCD prescription had no SCD during FU. These findings support the practice of careful risk stratification before considering an ICD and the use of the WCD for temporary protection from SCD.